A. Magnano

Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.

S. Martelli, I. Antonini, P. Polucci, 2004, Journal of medicinal chemistry.

Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.

S. Martelli, I. Antonini, P. Polucci, 2003, Bioorganic & medicinal chemistry.

Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.

S. Martelli, I. Antonini, P. Polucci, 2001, Journal of medicinal chemistry.

2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.

B. Gatto, M. Palumbo, S. Martelli, 2002, Journal of medicinal chemistry.

Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.

B. Gatto, M. Palumbo, S. Martelli, 2003, Journal of medicinal chemistry.

Synthesis and biological evaluation of indazolo[4,3-bc][1,5]naphthyridines (10-aza-pyrazolo[3,4,5-kl]acridines): a new class of antitumor agents.

G. Santoni, C. Amantini, I. Antonini, 2004, Bioorganic & medicinal chemistry.